Citations

Showing 10 of 108094 citations.

A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Chodnicki, Kevin D. , Kalarn, Sachin , Quinn, Laura A. , Jampel, Henry , Chodnicki, Kevin, Saeedi, Osamah J.

Mayo Clinic

Journal of Glaucoma | January 5, 2018 | Volume: 27 | Issue: 3 | Pages: 233-238

10.1097/ijg.0000000000000861 | PMID 29303871 Get It

Purpose: To describe state laws that govern the optometric practice of glaucoma management in the United States and to correlate those laws with state demographics upto 2015. Materials and Methods: We performed a cross-sectional ecological study of the 50 United States and the District of Columbia. Regulations governing optometric scope of practice as written by each state Board of Optometry were reviewed. Specific optometric privileges assessed included: ability to manage glaucoma independently, use of diagnostic pharmaceutical agents, use of therapeutic pharmaceutical agents (including topical and oral steroids and other oral pharmaceutical agents), IV injections, intraocular injections, therapeutic lasers, presence of defined referral, and comanagement guidelines, and hours of yearly continuing education needed for glaucoma management. Optometric privilege was compared with demographic and employment information for each state. Results: Optometrists in all states, except for Massachusetts, and the District of Columbia are allowed to manage glaucoma; 16 states have defined comanagement guidelines. Therapeutic lasers are allowed in 3 states: Kentucky, Louisiana, and Oklahoma. States with defined comanagement guidelines had a mean of 6.9±1.9 ophthalmologists per 100,000 people, significantly more than the 5.3±1.1 in states without defined comanagement of glaucoma (P<0.01). Binary logistic regression showed that, accounting for population and area, the higher the number of optometrists in a state, the less likely there is to be defined comanagement [β (SE)=−0.008 (0.003), P=0.02] and the greater the number of ophthalmologists in a given state, the more likely a state has defined comanagement [β (SE)=−0.13 (0.006)]. Conclusions: There is a diversity of regulations that govern optometric management of glaucoma in each of the 50 states and the District of Columbia. The number of optometrists and ophthalmologists in a state may influence state regulations governing optometric practice and referral guidelines.
Lessons From Recent Randomized Clinical Trials of Binocular Treatment for Amblyopia
Holmes, Jonathan M. , Holmes, Jonathan M.

Mayo Clinic

JAMA Ophthalmology | January 4, 2018 | Volume: 136 | Issue: 2 | Pages: 181

10.1001/jamaophthalmol.2017.5938 | PMID 29302679 Get It

Medial Open Transversus Abdominis Plane (MOTAP) Catheters Reduce Opioid Requirements and Improve Pain Control Following Open Liver Resection
Karanicolas, Paul J. , McHardy, Paul , Kiss, Alex , Sawyer, Jason , Behman, Ramy , Ladak, Salima , McCluskey, Stuart A. , Srinivas, Coimbatore, Katz, Joel , Coburn, Natalie G. , Law, Calvin , Wei, Alice C. , Greig, Paul D., Hallet, Julie , Clarke, Hance , Cleary, Sean, Cleary, Sean P.

Mayo Clinic

Annals of Surgery | January 4, 2018 | Volume: 268 | Issue: 2 | Pages: 233-240

10.1097/sla.0000000000002657 | PMID 29300708 Get It

Objective: Conventional management of pain following open liver resection involves intravenous, patient-controlled analgesia (IV PCA) or epidural analgesia. The objective of this trial was to assess the efficacy of a regional technique called Medial Open Transversus Abdominis Plane (MOTAP) catheter analgesia compared with IV PCA. Methods: This was a blinded, randomized, controlled parallel-arm trial conducted at 2 high-volume centers. Patients undergoing liver resection through a subcostal incision were enrolled. Using a standardized technique, 2 catheters were placed after resection: one in the plane between internal oblique and transversus abdominis and the other in the posterior rectus sheath. Patients were randomized to receive ropivacaine 0.2% (ROP) or saline (NS) through both catheters for 72 hours. All patients received IV PCA with hydromorphone as part of a multimodality analgesia program. Primary outcome was opioid use over the first 48 hours. Results: One hundred fifty-three patients were included in the analysis (71 ROP, 82 NS). Patients receiving ROP used significantly less opioid than patients with NS at 48 hours (median 39.6 mg morphine-equivalent vs 49.2 mg, P = 0.033) and at 72 hours (median 50.0 vs 66.4 mg, P = 0.046). Pain scores at rest and with coughing were significantly lower at all time points in patients who received ROP (P = 0.002). Median length of hospital stay was 5 days in patients receiving ROP and 6 days in patients who received NS (P = 0.035). There was no difference between groups in complications [ROP 20 (28.2%) vs NS 26 (31.7%), P = 0.63]. Conclusion: MOTAP catheter analgesia reduces opioid requirements, pain, and length of hospital stay compared with IV PCA following open liver resection with subcostal incisions.
Electrophysiology of Cranial Nerve Testing: Spinal Accessory and Hypoglossal Nerves
Stino, Amro , Smith, Benn E.

Mayo Clinic

Journal of Clinical Neurophysiology | January 4, 2018 | Volume: 35 | Issue: 1 | Pages: 59-64

10.1097/wnp.0000000000000439 | PMID 29298213 Get It

Summary: Multiple techniques have been developed for the electrodiagnostic evaluation of cranial nerves XI and XII. Each of these carries both benefits and limitations, with more techniques and data being available in the literature for spinal accessory than hypoglossal nerve evaluation. Spinal accessory and hypoglossal neuropathy are relatively uncommon cranial mononeuropathies that may be evaluated in the outpatient electrodiagnostic laboratory setting. A review of available literature using PubMed was conducted regarding electrodiagnostic technique in the evaluation of spinal accessory and hypoglossal nerves searching for both routine nerve conduction studies and repetitive nerve conduction studies. The review provided herein provides a resource by which clinical neurophysiologists may develop and implement clinical and research protocols for the evaluation of both of these lower cranial nerves in the outpatient setting.
Neurophysiology of Cranial Nerves I-XII
Smith, Benn E.

Mayo Clinic

Journal of Clinical Neurophysiology | January 4, 2018 | Volume: 35 | Issue: 1 | Pages: 1-2

10.1097/wnp.0000000000000438 | PMID 29298207 Get It

Comparing Measures of HDL: On the Right Path with the Wrong Map
Meeusen, Jeffrey W.

Mayo Clinic

Clinical Chemistry | January 4, 2018 | Volume: 64 | Issue: 3 | Pages: 424-426

10.1373/clinchem.2017.284208 | PMID 29301750 Get It

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Miao, Diana , Margolis, Claire A. , Gao, Wenhua , Voss, Martin H. , Li, Wei , Martini, Dylan J. , Norton, Craig, Bossé, Dominick , Wankowicz, Stephanie A. , Cullen, Dana, Horak, Christine E., Wind‐Rotolo, Megan , Tracy, Adam , Giannakis, Marios , Hodi, F. Stephen , Drake, Charles G. , Ball, Mark W. , Hellmann, Matthew D. , Ho, Thai H. , Kaelin, William G. , Choueiri, Toni K. , Hodi, Frank Stephen , Allaf, Mohamad E , Snyder, Alexandra , Hellmann, Matthew D , Ho, Thai , Motzer, Robert J , Signoretti, Sabina , Kaelin, William G , Choueiri, Toni K , Van Allen, Eliezer M , Voss, Martin H , Motzer, Robert J.

Mayo Clinic

Science | January 4, 2018 | Volume: 359 | Issue: 6377 | Pages: 801-806

10.1126/science.aan5951 | PMID 29301960 Get It

SNF'ing out antitumor immunity Immune checkpoint inhibitors induce durable tumor regressions in some, but not all, cancer patients. Understanding the mechanisms that determine tumor sensitivity to these drugs could potentially expand the number of patients who benefit (see the Perspective by Ghorani and Quezada). Pan et al. discovered that tumor cells in which a specific SWI/SNF chromatin remodeling complex had been experimentally inactivated were more sensitive to T cell–mediated killing. The cells were more responsive to interferon-γ, leading to increased secretion of cytokines that promote antitumor immunity. Miao et al. examined the genomic features of tumors from patients with metastatic renal cell carcinoma who had been treated with immune checkpoint inhibitors. Tumors harboring inactivating mutations in PBRM1 , which encodes a subunit of the same SWI/SNF complex, were more likely to respond to the drugs. Science , this issue p. 770 , p. 801 ; see also p. 745
Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology
Safarova, Maya , Safarova, Maya S, Kullo, Iftikhar J.

Mayo Clinic

Circulation Research | January 4, 2018 | Volume: 122 | Issue: 1 | Pages: 26-27

10.1161/circresaha.117.312319 | PMID 29301842 Get It

Bulbar Conjunctival Nodule in a Patient With Rheumatoid Arthritis
Starr, Matthew R. , Louwagie, Curtis R., Salomão, Diva R. , Starr, Matthew R

Mayo Clinic

JAMA Ophthalmology | January 4, 2018 | Volume: 136 | Issue: 4 | Pages: 438

10.1001/jamaophthalmol.2017.4271 | PMID 29302686 Get It

Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?
Nguyen, Daniel P. , Sharma, Vidit , Corradi, Renato B., Vilaseca, Antoni , Sjoberg, Daniel D. , Benfante, Nicole , Fine, Samson W. , Reuter, Victor E. , Scardino, Peter T. , Eastham, James A., Karnes, R. Jeffrey , Touijer, Karim, Vertosick, Emily , Takeda, Toshikazu

Mayo Clinic

Journal of Urology | January 4, 2018 | Volume: 199 | Issue: 6 | Pages: 1502-1509

10.1016/j.juro.2017.12.056 | PMID 29307681 Get It